Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar

Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar

Background: Infectious endocarditis (ie) is a serious and potentially fatal illness. Epidemiology, treatment options and results have changed considerably over the past two decades. The objective of the study was to describe epidemiology, clinical features and results of Qatar IE patients.

Methods: Patients were identified in the Hamad Medical Corporation Corporation’s electronic archives, the National Reference Center for Qatar State. We included 18-year-olds with a DUC diagnosis of DUC in the period from January 2015 to September 2017. Demographic and clinical data were recovered. Descriptive statistics were performed and a logistic regression analysis was used to describe the relationship between patient characteristics and hospital mortality. All potentially relevant variables have been included in the univariate analysis, while those with P <0,1 in the UNIVARIARY logistics regression model have been included in multivariate analysis. For the final template, we calculated dimension ratios (or) adjusted for each of the included variables, as well as their 95% confidence intervals (95% CI). The data was analyzed using Stata Software Version 15 (Statacorp, College Station, Texas, United States). The study was approved by the Council for Institutional Research with a renunciation of informed consent.

Results: Fifty-seven cases have been included, 70% of whom were men. The average age was 51 (± 16.8 years). Eleven (19%) were associated with prosthetic valves and 6 (11%) with implantable cardiac devices. Fever (84%), dyspnea (46%) and heart failure (37%) were the most common presentations. Only 58% of patients had pre-existing valvular heart disease or intracardiac. Cutaneous infections (10 patients, 18%) were the most common infection portals, followed by venous catheters, recent valve surgery and implantable heart devices. Staphylococci were involved in 19 (34%) and streptococcaceae in 9 patients (16%), while 21 patients (37%) were negative of culture. The target left (49 patients, 86%) was predominant.

 

Educational learning: mutual exchange between high school students and graduate students in the field of microbiology

The pedagogical learning process becomes more attractive when practical classes are used as part of methodological tools. Aim (i) stimulate the interest of high school students in the microbiological world and (ii) provide a didactic experience for graduate microbiology students, practical courses have been undertaken. These courses were conducted in the years 2016 and 2017, using the infrastructure held in Federal Viçosa Univeridade.

In short, laboratory classes have been prepared and taught by graduate microbiology students and an evaluation questionnaire has been answered by participants after classes. About 95% of high school students, two years, have evaluated the experience outside of the school routine as very good and good. A total of 90.09% (2016) and 100% (2017) graduate students evaluated this experience as good and good. The relationship between high school students and graduate students has also increased the curiosity of the first on the university environment.

As a result, the retention of information concerning the “world of microbiology” has been verified after one year and the students were able to remember the important terms related to the microbiology class. In addition, this work has allowed students graduate students and high school students to create a closer relationship and create an excellent pedagogical learning strategy for both.

 Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar
Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar

Tackling the pollution of real environmental paper: a microbiology lesson based on problems on carbon assimilation

Government and educational organizations advocate for the adoption of student-centered educational strategies in the Undergraduate programs. These strategies are known to benefit students by increasing performance and improving the control of the content of the class and increasing the content of the class and increasing the effect, particularly in students of racial / ethnic minorities underrepresented . Among these strategies, the case study and project-based learning allow students to master courses while collectively addressing relevant and real society issues. In particular, environmental pollution with paper-based products offers a microbiology problem on which microbiology students discover the role of microorganisms in paper waste management as well as microbiological and biochemical processes involved in the Secretion of proteins, the absorption of nutrients and energy metabolism.

Delivered in a hybrid class returned to an active learning laboratory (TEAL) activated by the technology, this lesson taught students about the secretion of exoenzyme, the hydrolysis of biopolymers, the intracellular transport of sugars and the catabolic reactions of sugar. Students have demonstrated an increased understanding of exoenzyme function and secretion, as well as how cells reach exoenzyme hydrolysis products. However, students had difficulty placing exoenzyme products transported in metabolic processes. Our results show increased perceived knowledge of students as well as understanding societal implications for these microbiological concepts. Our deviated lesson from knowledge silos in which students learn information in discrete topics.

Cefuroxime (sodium)

HY-B1256 1g
EUR 192

Cefuroxime

GA9610-100MG 100 mg
EUR 84

Cefuroxime

GA9610-1G 1 g
EUR 187.2

Cefuroxime

GA9610-250MG 250 mg
EUR 112.8

Nigericin sodium salt

2096-25
EUR 464.4

Nigericin sodium salt

2096-5
EUR 176.4

Thyroxine (Sodium salt)

30-AT52 1 gram
EUR 422.4
Description: High purity Thyroxine sodium salt

Triiodothyronine (Sodium salt)

30-AT53 1 gram
EUR 1018.8
Description: High purity (>99%) Triiodothyronine sodium salt

NADP, sodium salt

2737-100
EUR 183.6

NADP, sodium salt

2737-1000
EUR 940.8

NADP, sodium salt

2737-500
EUR 548.4

Ampicillin, Sodium Salt

A4004-005 5g
EUR 111.6

Ampicillin, Sodium Salt

A4004-025 25g
EUR 206.4

Ampicillin, Sodium Salt

A4004-100 100g
EUR 370.8

Sivelestat sodium salt

A4430-10 10 mg
EUR 205.2
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Sivelestat sodium salt

A4430-25 25 mg
EUR 408
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Sivelestat sodium salt

A4430-5 5 mg
EUR 141.6
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Sivelestat sodium salt

A4430-50 50 mg
EUR 673.2
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Fostriecin sodium salt

A4536-.1 100 µg
EUR 584.4
Description: IC50: Inhibit protein phosphatase types 2A (PP2A) and 4 (PP4) intensively with an IC50 of 1.5 nM and 3 nM respectively. Inhibit topoisomerase II (Topo II) and protein phosphatase type 1 (PP1) slightly with an IC50 of 40 ?M and 131 ?M respectively.

Fostriecin sodium salt

A4536-.5 500 µg
EUR 1762.8
Description: IC50: Inhibit protein phosphatase types 2A (PP2A) and 4 (PP4) intensively with an IC50 of 1.5 nM and 3 nM respectively. Inhibit topoisomerase II (Topo II) and protein phosphatase type 1 (PP1) slightly with an IC50 of 40 ?M and 131 ?M respectively.

Cefotaxime Sodium Salt

20-abx082178
  • EUR 260.40
  • EUR 210.00
  • 100 mg
  • 5 g

PIPES Sodium Salt

20-abx082438
  • EUR 326.40
  • EUR 226.80
  • 250 g
  • 25 g

Carboxymethylcellulose sodium salt

abx082467-100g 100 g
EUR 226.8

Ampicillin Sodium Salt

abx082587-5g 5 g
EUR 210

Cefotaxime Sodium Salt

abx188641-100g 100 g
EUR 610.8

Tianeptine Sodium Salt

abx188914-25g 25 g
EUR 376.8

Ampicillin Sodium Salt

AK0839-0010 10g Ask for price

Ampicillin Sodium Salt

AK0839-0025 25g Ask for price

Ampicillin Sodium Salt

AK0839-0100 100g Ask for price

Heparin Sodium Salt

AK3004-1000 1g Ask for price

Heparin Sodium Salt

AK3004-5000 5g Ask for price

Proglumide sodium salt

B5121-100 100 mg
EUR 166.8

Proglumide sodium salt

B5121-5.1 10 mM (in 1mL DMSO)
EUR 180

GSK1349572 sodiuM salt

B5856-10 10 mg
EUR 379.2
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

GSK1349572 sodiuM salt

B5856-100 100 mg
EUR 1452
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

GSK1349572 sodiuM salt

B5856-5 5 mg
EUR 289.2
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

GSK1349572 sodiuM salt

B5856-50 50 mg
EUR 873.6
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

Resazurin sodium salt

B6098-1000 1 g
EUR 100.8
Description: The non-fluorescent resazurin has been used as a fluorogenic oxidation-reduction indicator in various cells by flow cytometry, fluorescence microscopy and high-throughput screening. Its red-fluorescent product, resorufin, has absorption/emission maxima ~575/585 nm.

Resazurin sodium salt

B6098-5000 5 g
EUR 199.2
Description: The non-fluorescent resazurin has been used as a fluorogenic oxidation-reduction indicator in various cells by flow cytometry, fluorescence microscopy and high-throughput screening. Its red-fluorescent product, resorufin, has absorption/emission maxima ~575/585 nm.

Dantrolene, sodium salt

B6329-100 100 mg
EUR 158.4

Dantrolene, sodium salt

B6329-5.1 10 mM (in 1mL DMSO)
EUR 129.6

Entacapone sodium salt

B1090-10 10 mg
EUR 166.8
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds.

Entacapone sodium salt

B1090-100 100 mg
EUR 385.2
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds.

Entacapone sodium salt

B1090-50 50 mg
EUR 277.2
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds.

Adapalene sodium salt

B1277-100 100 mg
EUR 170.4
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR).

Adapalene sodium salt

B1277-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR).

Adapalene sodium salt

B1277-50 50 mg
EUR 129.6
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR).

Novobiocin Sodium Salt

B1526-1G
EUR 130.8

Novobiocin Sodium Salt

B1526-5G
EUR 288

Cefazolin Sodium Salt

B1530-1G
EUR 170.4

Cefazolin Sodium Salt

B1530-5G
EUR 430.8

HEPES Sodium salt

B7303-250000 250 g
EUR 343.2

CHPG Sodium salt

B7475-10 10 mg
EUR 303.6

CHPG Sodium salt

B7475-50 50 mg
EUR 1082.4

Nigericin sodium salt

B7644-10 10 mg
EUR 157.2
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane.

Nigericin sodium salt

B7644-25 25 mg
EUR 254.4
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane.

Nigericin sodium salt

B7644-5 5 mg
EUR 122.4
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane.

Bialaphos (sodium salt)

B7852-100 100 mg
EUR 289.2
Description: The antibiotic bialaphos (or SF1293) is a natural non-selective phytotoxin produced by Streptomyces hygroscopicus. Bialaphos is a tripeptide consisting of two L-alanine molecules and an L-glutamic acid analogue called phosphinothricin.

Bialaphos (sodium salt)

B7852-50 50 mg
EUR 216
Description: The antibiotic bialaphos (or SF1293) is a natural non-selective phytotoxin produced by Streptomyces hygroscopicus. Bialaphos is a tripeptide consisting of two L-alanine molecules and an L-glutamic acid analogue called phosphinothricin.

Sulfamerazine sodium salt

B3430-100000 100 g
EUR 164.4
Description: Sulfamerazine Sodium is a sulfonamide antibacterial.

Sulfamerazine sodium salt

B3430-50000 50 g
EUR 132
Description: Sulfamerazine Sodium is a sulfonamide antibacterial.

GSK2190915 sodium salt

B4905-10 10 mg
EUR 514.8

GSK2190915 sodium salt

B4905-5 5 mg
EUR 332.4

GSK2190915 sodium salt

B4905-5.1 10 mM (in 1mL DMSO)
EUR 456

GSK2190915 sodium salt

B4905-50 50 mg
EUR 1858.8

Ischemin sodium salt

B4917-10 10 mg
EUR 321.6

Ischemin sodium salt

B4917-50 50 mg
EUR 1167.6

Cefoxitin Sodium Salt

B1892-1G
EUR 222

Cefoxitin Sodium Salt

B1892-500
EUR 157.2

Cefoxitin Sodium Salt

B1892-5G
EUR 692.4

Azlocillin sodium salt

B1893-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria.

Azlocillin sodium salt

B1893-50 50 mg
EUR 153.6
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria.

Azlocillin sodium salt

B1893-S Evaluation Sample
EUR 97.2
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria.

(±)-Cloprostenol sodium salt

B7004-1 1 mg
EUR 134.4

(±)-Cloprostenol sodium salt

B7004-10 10 mg
EUR 435.6

(±)-Cloprostenol sodium salt

B7004-5 5 mg
EUR 360

CAPS, sodium salt

CB0097 50g
EUR 86.1

CAPSO, sodium salt

CD0041 50g
EUR 91.32

Hepes, Sodium Salt

CH039 25 g
EUR 141.6

Hepes, Sodium Salt

CH040 100 g
EUR 202.8

Hepes, Sodium Salt

CH041 500 g
EUR 448.8

Cefamandole sodium salt

C079-100MG 100 mg
EUR 177.6

Cefamandole sodium salt

C079-500MG 500 mg
EUR 568.8

Methicillin (sodium salt)

C3238-100 100 mg
EUR 174
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Methicillin (sodium salt)

C3238-250 250 mg
EUR 271.2
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Methicillin (sodium salt)

C3238-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Methicillin (sodium salt)

C3238-50 50 mg
EUR 129.6
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Ertapenem (sodium salt)

C3451-10 10 mg
EUR 289.2
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1].

Ertapenem (sodium salt)

C3451-25 25 mg
EUR 537.6
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1].

Ertapenem (sodium salt)

C3451-5 5 mg
EUR 195.6
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1].

Cefamandole (sodium salt)

C3541-100 100 mg
EUR 292.8
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".

Cefamandole (sodium salt)

C3541-50 50 mg
EUR 182.4
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".

Cefamandole (sodium salt)

C3541-500 500 mg
EUR 710.4
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".

Lorglumide (sodium salt)

C4809-25 25 mg
EUR 174
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] .

Lorglumide (sodium salt)

C4809-50 50 mg
EUR 205.2
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] .

Cefoxitin (sodium salt)

C4849-1000 1 g
EUR 289.2
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Cefoxitin (sodium salt)

C4849-250 250 mg
EUR 135.6
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Cefoxitin (sodium salt)

C4849-500 500 mg
EUR 196.8
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Fosmidomycin (sodium salt)

C4898-10 10 mg
EUR 498
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Fosmidomycin (sodium salt)

C4898-25 25 mg
EUR 996
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Fosmidomycin (sodium salt)

C4898-5 5 mg
EUR 292.8
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Simvastatin (sodium salt)

C4426-100 100 mg
EUR 470.4
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs.

Simvastatin (sodium salt)

C4426-25 25 mg
EUR 235.2
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs.

Moniliformin (sodium salt)

C4459-1 1 mg
EUR 385.2
Description: Moniliformin induces mitotic arrest at the metaphase stage.Mitosis is a part of the cell cycle when replicated chromosomes are separated into two new nuclei.

Cefotaxime (sodium salt)

C4588-1000 1 g
EUR 151.2
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)

C4588-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)

C4588-500 500 mg
EUR 129.6
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)

C4588-5000 5 g
EUR 181.2
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Narasin (sodium salt)

C3061-25 25 mg
EUR 804
Description: IC50: 3.2 ?M: blocks NF-?B signaling via inhibition of I?B? phosphorylationNarasin, isolated from certain Streptomyces sp. is an ionophore antibiotic.

Narasin (sodium salt)

C3061-5 5 mg
EUR 224.4
Description: IC50: 3.2 ?M: blocks NF-?B signaling via inhibition of I?B? phosphorylationNarasin, isolated from certain Streptomyces sp. is an ionophore antibiotic.

Moxalactam (sodium salt)

C4121-1000 1 g
EUR 270
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)

C4121-250 250 mg
EUR 134.4
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)

C4121-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)

C4121-500 500 mg
EUR 201.6
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Cefazolin (sodium salt)

C4183-1000 1 g
EUR 201.6
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)

C4183-250 250 mg
EUR 126
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)

C4183-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)

C4183-500 500 mg
EUR 165.6
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Tazobactam (sodium salt)

C4245-1000 1 g
EUR 271.2
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Tazobactam (sodium salt)

C4245-250 250 mg
EUR 139.2
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Tazobactam (sodium salt)

C4245-500 500 mg
EUR 201.6
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Cefonicid (sodium salt)

C3812-1000 1 g
EUR 487.2
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

Cefonicid (sodium salt)

C3812-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

While avoiding employing traditional and compartmentalized learning approaches, this student-centered guided lesson frames the systemic nature of the microbiological and biochemical processes underlying the decomposition of organic matter in a context of the real world. Anemia is a risk factor for negative results, which can be aggravated by unnecessary phlebotomies. In blood culture tests, up to 30 ml of blood can be removed by sample, although most manufacturers recommend blood volumes of 10 ml or less. After evaluating the volume of filling blood culture bottles in our institution, we investigated the question of whether an educational intervention could optimize the volume of blood culture bottles without negatively affecting microbiology tests.

Leave A Comment